The EU Falsified Medicines Directive (FMD) no longer applies to medicines supplied in Great Britain post-Brexit, but Northern Ireland still operates under the FMD framework as part of the Windsor Framework arrangements. The MHRA has indicated its intent to develop a UK-specific anti-falsification framework. This piece walks through the current state and what UK telehealth operators need to know.
Where the EU FMD applies in 2026
The EU Falsified Medicines Directive requires verification and decommissioning of unique identifiers on prescription medicine packs at supply to the patient. Post-Brexit, the FMD requirements no longer apply to medicines supplied in Great Britain. Northern Ireland remains within the FMD framework as part of the Windsor Framework arrangements.
For UK telehealth supplying patients in Great Britain (England, Scotland, Wales), FMD scanning and decommissioning is not required. For services supplying Northern Ireland patients, FMD-style verification continues.
What this means for GB telehealth pharmacy operations
GB-based pharmacies no longer maintain the FMD verification infrastructure that was required pre-2021. Pack scanning equipment, integration with the UK medicines verification system, and the operational SOPs around decommissioning have been wound down for most GB operations.
MHRA has indicated it intends to develop a UK-specific anti-falsification framework, but as of 2026 there is no operational UK equivalent in place for GB medicines. The regulatory expectation is the standard medicines supply discipline — verified suppliers, proper sourcing, inspection trail.
Northern Ireland and the Windsor Framework
Northern Ireland operates within the EU FMD framework. Pharmacies in NI must continue to verify and decommission unique identifiers on prescription medicines. Telehealth services supplying NI patients need to ensure their supply chain handles FMD verification appropriately.
The practical implication for UK telehealth: services that operate across GB and NI need to handle the NI supply via FMD-compliant pharmacy operations, while GB supply does not require the same. Most UK telehealth services either operate only GB or partition NI supply through NI-based pharmacy.
Anti-falsification discipline absent FMD
Even without the FMD framework operating in GB, anti-falsification discipline matters. Sourcing medicines only through WDA-licensed wholesalers, maintaining inspection trail from manufacturer to dispense, refusing supply from unverified channels — these remain foundational. The risk of falsified medicines entering the supply chain has not disappeared; the regulatory framework around it has changed.
Brands operating with proper supply discipline are protected by the discipline itself. Brands sourcing carelessly — through unverified intermediaries or with poor inspection trail — face risk regardless of which regulatory framework applies.
How PExpo handles supply chain and anti-falsification
PExpo's dispensing operation sources medicines through WDA-licensed UK wholesalers with proper inspection trail. The operational discipline around supply chain integrity is maintained regardless of the FMD framework status. For NI supply where required, the appropriate framework applies.
See our brand model page for the operational scope and our pricing page for the commercial structure.
EU FMD does not apply in Great Britain in 2026. Northern Ireland still operates under FMD via the Windsor Framework. Anti-falsification discipline matters regardless — proper sourcing through WDA-licensed wholesalers remains foundational.
The risk of falsified medicines entering the supply chain has not disappeared. The regulatory framework around it has changed. Sourcing discipline matters.
FMD requirements no longer apply to medicines supplied in Great Britain post-Brexit, though Northern Ireland still operates under FMD via the Windsor Framework. MHRA has indicated intent to develop a UK-specific anti-falsification framework. Operational supply chain discipline matters regardless of which framework applies. See our brand model page for how PExpo handles supply chain integrity.
Frequently asked questions
Do I need to scan packs at dispense in GB pharmacy in 2026?
No — FMD scanning and decommissioning is not required for GB-supplied medicines post-Brexit. The standard medicines supply discipline applies.
Does PExpo dispense to Northern Ireland?
PExpo's primary operations focus on Great Britain. For Northern Ireland supply, specific FMD-compliant arrangements would apply. Discuss specifics with our team if you intend to supply NI patients.
Will UK reintroduce an FMD-equivalent framework?
MHRA has indicated intent to develop a UK-specific anti-falsification framework, but no operational equivalent is in place in GB in 2026. Watch MHRA communications for updates.
